Close Menu

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion.

Presented by Russell Garlick PhD - CSO LGC Clinical Diagnostics SeraCare LIfe Sciences
Karen Gutekunst PhD - VP of Regulatory Affairs Illumina
Bob Daber PhD - President and CTO Genosity
Federico Goodsend PhD - Principal Regulatory Pathfinders LLC
Jinjie Hu PhD - Principal Consultant for Axteria BioMed

Sponsored by

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.